chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt Pfizer dose 0.3cc was given by healthcare professional @1718.  Pt c/o that the room was swaying and numbness/tingling around mouth @ 1735.  Vitals:  BP 140/92 pulse 96 resp.20.  Pt was given water and instructed to hydrate.  Pt was then transfered to an area with nurse and placed supine with legs elevated on chair.  Vitals @ 1745 160/110 pulse112 resp. 20.  Vitals @1750 140/100 pulse 100 and resp 18.  Pt then c/o of nausea and therefore was helped to a sitting position with a waste basket nearby.  Pt @ 1805 c/o chills with continued nausea and emesis of  water and food particles.  Pt's numbness and tingling was now bilaterally at the level of her cheeks.  Vitals 37.1 Bp 140/120 pulse 112 resp 18. At 1810, after consulting with nurse made the decision to have employee to call 911.  Vitals @ 1820 180/130 pulse 112 and resp 18.  Paramedics arrived @1824.  Assessment was made by parametics and pt. agreed to be transferred to ER for further evaluation.  Pt's sister accompanied patient to the ER via ambulance.
Signs/Symptoms: Tingling in lips and hard palate.  Treatment: Benadryl PO
Patient came in on 10102023 at approximately 04:50 PM  to let us know  at the pharmacy what  he had been feeling after getting both his RSV and Flu Vaccination(s). Patient stated that he felt mild pain on the back of his left hand after  getting the vaccination and didn't think too much about it. When asking how he felt today, 10/10/2023, patient had stated that he felt fine overall but would like this to be documented.
Ongoing red circle at injection site 10 days later. Spot is firm to the touch.
On multiple unspecified dates, multiple unspecified patientes received improperly stored vaccine; No adverse effect; This spontaneous report has been received from a medical assistant, concerning a 61-week-old female patient.   The patient's concurrent conditions, historical conditions, previous drug reactions, or allergies and concomitant medication were not reported.  On 25-APR-2019, the patients were vaccinated with improper stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # R000555 and expiration date 08-JAN-2020) (anatomical location not reported) for prophylaxis. The measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) vaccine was reconstituted with properly stored sterile diluent. No adverse effects reported.  Additionally, temperature for vaccines were total time and highest temperature above 9°C (9.9 C); time frame: 4 hours; with no previous temperature excursion. The error was identified via a data logger.; Sender's Comments:  US-009507513-1903USA013366:
Sore arm, sometimes hurts still a month later, lymph nodes are swollen on left side.
She said that she is experiencing diarrhea after the first dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program (159558). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 16Apr2021 (Batch/Lot number: unknown) at the age of 65 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "She said that she is experiencing diarrhea after the first dose". Additional information: second dose was scheduled on 07May2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
got the vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (got the vaccine while pregnant) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 20-Feb-2022. On 27-Oct-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (got the vaccine while pregnant). On 27-Oct-2021, MATERNAL EXPOSURE DURING PREGNANCY (got the vaccine while pregnant) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.  It was reported that the second shot was scheduled on 24-Nov-2021. Company comment: This is a case of Maternal exposure during pregnancy for this 41-year-old female patient. Reportedly, the patient received the first dose of Moderna COVID-19 Vaccine during pregnancy. The patient's last menstrual period was not provided, and as per the estimated date of delivery, the patient received this first dose approximately during the sixth month of pregnancy (however, this information will be confirmed during follow up). No adverse events were reported at the time of this report. The company causality for the event of Maternal exposure during pregnancy is not applicable. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.; Sender's Comments: This is a case of Maternal exposure during pregnancy for this 41-year-old female patient. Reportedly, the patient received the first dose of Moderna COVID-19 Vaccine during pregnancy. The patient's last menstrual period was not provided, and as per the estimated date of delivery, the patient received this first dose approximately during the sixth month of pregnancy (however, this information will be confirmed during follow up). No adverse events were reported at the time of this report. The company causality for the event of Maternal exposure during pregnancy is not applicable. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Rash; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received Shingrix vaccine and experienced rash following the shot.
Mother stated that immediately after returning home from vaccination clinic that patient began to cough Tuesday 8/03/2010, and he has had persistant coughing ever since.  He eventually developed a fever Friday 8/6 and went to see his private physician.  Physician did not make any diagnosis at this time.  Symptoms continued to get worse so he went to Urgent Care Center on Sunday 8/8 and was diagnosed with Pneumonia.  Patient went to see private physician again on Monday 8/9 also diagnosed with ear infection.  Tuesday 8/10- one week post vaccination his fever remained above 100 degrees, Wednesdsay 8/11 child developed severe abdominal pain and went to Emergency Department for CT scan.  Mother stated to RN that CT scan showed a thickening of the intestinal wall.  Patient returned to Private Physician on 08/12 and continues to have abdominal pain.
pt recv 1 dose varivax 4/96 & in 4/98 pt devel 12-15 chickenpox, low grade fever
I have experience an overwhelming headache everyday since receiving the vaccine. OTC medicines; ibuprofen acetomenaphin, and naproxen are not relieving.  I was prescribed Sumatriptan today and have taken 2 doses, also with no relief.
headache after the second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of HEADACHE (headache after the second dose) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, the patient experienced HEADACHE (headache after the second dose). At the time of the report, HEADACHE (headache after the second dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details provided.  No Treatment medication details provided.   This case was linked to MOD-2021-162301 (Patient Link).
Patient called the pharmacy about pain, swelling, redness, and limited mobility in her shoulder. I explained to the patient that this is probably related to how the immunization was administered. I also explained that my team would get back to her about what her next steps would be in regards to going to see her primary care physician to treat the symptoms.
Beginning about 12 hours after  receiving the shot, I began running fever, with body aches and chills and headache. This continued for 2 days.  I also had a severe extreme fatigue, which lasted for 2 days and then mild fatigue for about 6 days after that.  About 48 hours after the shot, a lymph node in the clavicle area became super enlarged and tender.  The tenderness went away after 24 hours, but the swelling remained for 2 weeks after that.   This is the first flu shot I received in the last 13 years.  I had an adverse reaction, a frozen arm 13 years ago and haven't gotten it since.  Last year I did receive the nasal flu vaccine with no side effects.
Stomach pain, massive really bad stomach cramps; Injection arm sore; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain, massive really bad stomach cramps) and VACCINATION SITE PAIN (Injection arm sore) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain, massive really bad stomach cramps) and VACCINATION SITE PAIN (Injection arm sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain, massive really bad stomach cramps) and VACCINATION SITE PAIN (Injection arm sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Immediately following administration of vaccines baby noted to have uticaria over entire body. Crying no respiratory distress. Immediately 0.05cc epi given SQ and 911 called. Paramedics arrived within 3 min. Uticaria by this time disappearing, noted slight cyansis around mouth-O2 by mask
Pain in left arm, left side of back and left leg all the way down, had a hard time getting out of bed.  Walked bent over "like an old man" from the pain.  He never had this before.  Mild headache.  Aleve helps completely, then pain comes back when it wears off.  Symptoms wax and wane, have persisted now for a month since the vaccine.  No joint swelling or redness.  No symptoms on right side at all. Never had these types of musculoskeletal symptoms before the vaccine.
This spontaneous report as received from a nurse refers to a unspecified number of patients of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with a dose of GARDASIL lot # J010668 expiration date 29-APR-2016, Lot # K006124 expiration date 02-FEB-2017, Lot # K007264 expiration date 02-MAR-2017 (dose and route were not reported). No co-suspect and concomitant therapies were reported. The nurse reported that Department of Health requested glycol thermometer readings that showed improper storage of the vaccine. Doses of vaccine may have been administered to an unspecified number of patients on unspecified dates. Nurse also stated according to the Sensitronic thermometer there had not been a temperature excursion in this refrigerator. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
One big hive below injection site, next morning bladder infection (haven't had one in 32 years) strange coincidence.
after discussing with patient vaccinations due. patient recieved a flucelvax vaccination after which patient stated she already recieved influenza vaccine from physician approx. 2 week prior.  patient was only interesed in receiving vaccine for shingles
Pediatric patient developed redness, warmth and mild tenderness in an area of about 6x4 Cm of the right deltoid about 24hrs post IM vaccination. Mother described unmeasured fever at home. Treatment included local ice packs and tylenol. Mother offered ibuprofen for fever one dose.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported   No treatment medication was reported
Within 1 minute, experienced flushing of face and some swelling of face, accompanied by increased pulse (went from 72 to 99) and frequent PACs (confirmed on Apple Watch EKG app).  Felt odd.  Flushing, fast pulse lasted for about 5 minutes, then gradually subsided.  Feeling of strangeness persisted for several hours.  This also occurred at injection 1 on 2/8/21 (Moderna Lot 013M20A).
Gave 0.1 ml sub-Q Jynneos/BN Vaccine Correct dose 0.5ml Sub-Q
Information has been received from a licensed practical nurse, (L.P.N.) concerning a female who was vaccinated with a 0.5 mL dose of Gardasil.  Subsequently the patient developed a rash all over her body after receiving Gardasil.  The patient sought unspecified medical attention.  At the time of the report it was unknown, if the patient had recovered.  There was no additional information.  Additional information has been requested. 02/12/2010 Initial and follow up information has been received from a licensed practical nurse concerning a 12 year old female patient, a student who on 04-JUN-2007, at approximately 3:00 pm, was vaccinated IM in the left deltoid with the first dose 0.5mL of GARDASIL (lot #657736/0385U). There was no illness at the time of vaccination. Following the vaccination onthat day, the patient developed "scattered erythematous round macules with some target lesions," also described as a rash all over her body. The patient was seen by the physician, though treatment was not specified. At the time of this report the patient had recovered (date and duration not specified). Additional information is not expected.
Pneumonia vaccine given in right deltoid at app 11:28am. Noticed arm was sore and swollen at app 5pm. put a cold compress on arm and took a Darvocet. unable to sleep for pain. Has not taken anything or used cold compress today 10/12/2005 suggested she take Tylenol and put cold compress on arm. Deltoid area is swollen and warm to touch no other complaints
Info has been received from a mother concerning her 12 year old son who had no medical history or allergies who in 9/95, was vaccinated with a dose of varicella virus vaccine live. There was no concomitant therapy. The pt's mother reported that on 10/15/05, her son developed chickenpox. Unspecified medical attention was sought and a throat culture was done (results not provided. On 10/21/05, the pt recovered from the chickenpox. Additional info has been requested.
A report has been received from a Health Professional concerning a 57 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 27-Nov-2013. The patient was inadvertently administered FLUMIST QUADRIVALENT who was 57 years old which started on 27-Nov-2013. The outcome of the event of inadvertently administered/we inadvertently administered FLUMIST QUADRIVALENT to a patient who is 57 years old is unknown. The report was considered to be non-serious.
Horrible fever blisters; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Horrible fever blisters) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ORAL HERPES (Horrible fever blisters). At the time of the report, ORAL HERPES (Horrible fever blisters) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
(Vaccinated in left arm): right jaw (inside) appears to have been slightly swollen. It felt like I was biting the inside of my jaw. I rinsed my mouth with warm salt-water. After slightly less than 24 hours, things returned to normal.
Fever of 99.7°F; Body aches; Headache; Pain on her legs; Very tired; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on her legs), FATIGUE (Very tired), CHILLS (Chills), PYREXIA (Fever of 99.7°F) and MYALGIA (Body aches) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 02-Dec-2020. Concomitant products included ESTROGENS CONJUGATED, MEDROXYPROGESTERONE ACETATE (PREMPRO) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain on her legs), FATIGUE (Very tired) and CHILLS (Chills). On 29-Jan-2021, the patient experienced PYREXIA (Fever of 99.7°F), MYALGIA (Body aches) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Pain on her legs), FATIGUE (Very tired), CHILLS (Chills), PYREXIA (Fever of 99.7°F), MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, Body temperature: 99.7°f Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information was not provided.
Initial report was received 03 December 2010 from a health care professional. An elderly female patient had received an injection of FLUZONE HIGH-DOSE, lot number U3608AA (route, site and date of administration not reported) and two days later, she could not move her shoulder. Outcome was not reported. No additional information was provided at the time of the report. Follow-up information was received from a health care professional on 08 December 2010. The patient was an 87-year-old female. The patient had a history of colon cancer, degenerative joint disease (DJD) and lymphoma. The patient's concomitant medications included prednisone (long term) and LEXAPRO. She had no known allergies (NKA) and no illness at the time of vaccination. The patient received an intramuscular left deltoid injection of the FLUZONE HIGH-DOSE on 08 November 2010. Two days after the vaccine on 10 November 2010, the patient could not move her left arm. She was seen in the office on 02 December 2010 and still could not move her left arm and had a tender tricep muscle. She was seen again in the office on 06 December 2010 and her arm movement improved during the 4 days on prednisone. When the patient stopped the prednisone, she could not move the left arm again. The outcome was reported as not recovered. Follow-up information was received from a health care professional on 03 January 2011 reported that the patient had received chemotherapy. She had no other vaccinations within 4 weeks of the FLUZONE HIGH DOSE. In May 2010, her oncologist had reported that when she was weaned off steroids all together, the patient noted more arthritic type pain in her arms and shoulders. The patient was put back on prednisone 5 milligrams (mg) a day after the flu vaccine for pain that was different in that she could not even raise her left arm. The patient was put on prednisone 20 mg for 4 days and then back to 5 mg daily. The patient felt better and cancelled her magnetic resonance imaging (MRI) that was scheduled for the 16 December 2010. However, the patient's left arm and shoulder pain still comes and goes. The patient was re-scheduled to have an MRI soon. The patient was treated for the pain with VOLTAREN. The outcome remained not recovered. Follow-up information received from a nurse on 07 February 2011. The patient spoke with the physician and stated she was feeling better, she cancelled her MRI again. The physician feels more comfortable that the patient's intermittent symptoms are probably due to her arthritis/DJD and not due to the vaccine. The subject has medical history of degenerative joint disease. Follow-up information was received from a health care professional on 14 March 2011. The reporter stated they had no additional information to provide at this time. The patient's outcome remained not recovered. Document held by sender: None.
Information has been received from a registered nurse concerning a female who was vaccinated with Gardasil. Subsequently the patient experienced dizziness. This is one of several reports from the same source. Additional information has been requested.
Nausea, severe diarrhea, chills, for minimum of 2 days
SORE ARM; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient initially received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, administered on JUN-2021 for prophylactic vaccination as primary vaccination (dose number in series 1). It was unknown whether patient had any adverse event following vaccination with first dose. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, administered on NOV-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced sore arm (Dose number in series 2).  On an unspecified date the patient reported that he was exposed to delta variant and quarantined but did not get sick. No additional information was provided. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was unknown. This report was non-serious.